Drug intelligence / Profile preview

XiangLian

Development stage
Preclinical
Lead developer
Ministry of Science and Technology
Modality
Small Molecules
Administration
Vaginal, Oral, Topical
01

Overview

XiangLian is a traditional Chinese medicine (TCM) formula, commonly known as Xianglian pill or Xianglian Wan, primarily composed of the herbs Coptidis Rhizoma (Huanglian) and Aucklandiae Radix (Muxiang). It has been historically used to "eliminate damp-heat, promote the flow of qi and relieve pain" for conditions like dysentery, abdominal pain, and diarrhea. Modern research indicates its therapeutic potential in various conditions, including recurrent vulvovaginal candidiasis, tinea pedis, antibiotic-associated diarrhea, ulcerative colitis, pancreatic cancer, dyslipidemia, and colorectal cancer. Its mechanisms of action are diverse, involving the regulation of inflammation, apoptosis, metastasis, and metabolism, inhibition of PTGS1/PTGS2, promotion of autophagy via the PI3K/Akt/mTOR pathway, modulation of gut microbiota and succinate production, induction of regulatory T cells, and inhibition of M1 macrophage polarization. Key active components include berberine, which has been shown to inhibit fatty acid synthase.

Other names
Xianglian pillXianglian WanXiangLian SuppositoryXiangLian lotionXiangLian creamtablet of XianglianXLP
02

Targets

NeuraminidaseUCP1 (Uncoupling protein 1)FASN (Fatty acid synthase)mTOR (Mammalian target of rapamycin kinase)MYD88 (Myeloid differentiation primary response protein MyD88)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)AKT (RAC-alpha serine/threonine-protein kinase)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on XiangLian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on XiangLian.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call